Sunday, April 6, 2025

India’s first intranasal vaccine for COVID gets DCGI approval

Date:

Share post:

New Delhi, Sep 6:  India’s first intranasal Covid vaccine by Bharat Biotech on Tuesday got the approval from the Drug Controller General of India for 18+ age group for restricted use in emergency situation.

Announcing the achievements, Union Health Minister Mansukh Mandaviya termed it a ‘big boost to India’s fight against Covid-19.

“Big Boost to India’s Fight Against COVID-19! Bharat Biotech’s ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted use in emergency situation,” Mandaviya tweeted.

In the subsequent tweet he said, “This step will further strengthen our collective fight against the pandemic.

“India has harnessed its science, R&D, and human resources in the fight against COVID-19 under PM @NarendraModi Ji’s leadership. With the science-driven approach & Sabka Prayas, we will defeat COVID-19”, he said.

IANS

Related articles

Shillong, Jowai students bag top position in SSLC merit list

 Leisha Agarwal from St Margaret’s HS School and Avila Kathrene P Lyngdoh of North Liberty HS School, Jowai jointly...

High pass percentage triggers applause, critical questions

Our Bureau SHILLONG, April 5: Meghalaya’s Secondary School Leaving Certificate (SSLC) pass percentage jumped from 55.80% in 2023 to...

Govt distances itself from NEIGRIHMS controversy

By Our Reporter SHILLONG, April 5: The Meghalaya government has distanced itself from the ongoing imbroglio in NEIGRIHMS which...

AAI notifies tender for expansion of Shillong Airport

By Our Reporter SHILLONG, April 5: The Airports Authority of India (AAI) has issued a tender notice for the...